Midi Health, a clinic focusing on women's health during midlife, announced securing $60 million in Series B funding led by Emerson Collective, bringing its total funding to $100 million. GV (Google Ventures), the lead investor in the company's Series A round, also participated. Other investors in the Series B round included SemperVirens, Icon Ventures, Felicis, Gingerbread Capital, Steel Sky Ventures, Black Angel Group, Memorial Hermann, K50 Ventures, Operator Collective, G9, 1843 Capital, Muse Capital, Able Partners, F7, Avestria, Anne Wojcicki, and Susan Wojcicki.
The California-based virtual care company specialises in women aged 40 and above experiencing perimenopause and menopause, offering a network of nurse practitioners overseen by physicians and researchers. It provides interventions ranging from lifestyle coaching to prescription medication. Midi Health plans to use the funds to expand insurance coverage nationwide, increase its clinician network by 150 members by the end of 2024, diversify its services, and expand its reach.
Joanna Strober, CEO and cofounder of Midi Health, emphasised the company's commitment to comprehensive, personalised care for women during midlife, addressing various health concerns beyond menopause.
Midi Health received a $14 million seed investment in 2022, co-led by Felicis and SemperVirens, who also participated in the Series B round. It partnered with Houston-based Memorial Hermann Health System to provide services to patients and expanded its virtual care clinic to employers in all 50 states starting January 2024.
In March, Midi Health collaborated with Neurotrack, a digital cognitive assessment company, to help women differentiate between menopause-related brain fog and signs of severe cognitive impairment like early dementia. Other companies in the women's perimenopausal and menopausal health space include Evernow and Ovia Health, which expanded its platform to include menopause-focused offerings in February.
Click here to read the original news story.